The effect of guanethidine and reserpine on the reflex sympathetic nervous system vasoconstriction in the calf and foot induced by a prolonged, generalized stimulus (body cooling for 1 hour) was studied in 12 normal subjects. Large daily clinical-doses of guanethidine (40 to 60 mg) or reserpine (1 mg) were given orally for 2 and 3 weeks, respectively. Foot and calf blood flows were measured by venous-occlusion, water plethysmography. Two control studies were performed on each subject, one before and another long after administration of the drug; body cooling produced significant decrease in calf and foot blood flow and increases in vascular resistance in both control studies. Subjects evidenced drug effects by a significant decrease in pulse rate, postural hypotension, hypotension following exercise, and blockade or attenuation of the Valsalva maneuver "overshoot." The attenuation of the sympathetic nervous-system vasoconstrictor reflex to general body cooling was not statistically significant.
GUANETHIDINE and reserpine have been found to attenuate or block responses of the sympathetic nervous system to certain acute stimuli, that is, exposure of a hand to ice water, exercise, emotional trauma. [1] [2] [3] This decrease in sympathetic activity has been attributed to depletion of peripheral catecholamine stores. However, at least one sympathetic reflex has been reported to persist when other sympathetic responses were inhibited by guanethidine,2 indicating that the sympathetic neurotransmitter substance (most likely norepinephrine) From the Department of Medicine, University Hospital, Boston University Medical Center, Boston, Massachusetts.
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Circulation, Volume XXXV, February 1967 Vasoconstrictor response was not entirely absent. Some investigators have also found that a pressor reaction occurs in response to intravenous tyramine, amphetamine, or ephedrine in human subjects receiving guanethidine or reserpine.4 Persistence of a pressor response to these amines would further indicate that norepinephrine must be present in quantities sufficient to cause vasoconstriction.
This study investigated, in normal subjects, the effect of oral guanethidine or reserpine on the reflex vasoconstriction resulting from a prolonged, generalized sympathetic stimulus (body cooling). It was felt that a prolonged and generalized stimulus would reveal neurotransmitter substance which might be present even though the drugs had attenuated or blocked the sympathetic responses to acute stimuli. The results of this study showed no statistically significant attenuation of the sympathetic vasoconstrictor reflex to total body 339 cooling and indicate that sympathetic neurotransmitter substance was not totally absent in these human subjects receiving clinical doses of guanethidine or reserpine for two and three weeks, respectively.
Methods
Total blood flow in the calf of one leg and in the opposite foot was measured by venous occlusion plethysmography on lightly clothed subjects lying in the supine position. Both legs were elevated to maintain the posterior aspect of the lower leg approximately at heart level. The right foot and left calf were enclosed in plethysmographs filled with water at a temperature of 93.2 F (calf) and 89.6 F (foot); water temperature was carefully maintained within a range of 1 F. The technique for enclosing the limb in the water plethysmograph has previously been described in detail. 5 The water level within the plethysmograph (10 cm above the calf or foot) produced a hydrostatic pressure equal to or slightly greater than natural local venous pressure. The circulation to the foot was excluded during calf flow measurements by an 8-cm-wide pneumatic cuff on the ankle inflated to 50 mm Hg above the subject's systolic pressure, as measured in the arm by the auscultatory method. Pneumatic cuffs, 13-cm wide, were placed above the left knee and on the right ankle proximal to the plethysmographs. Inflation of these cuffs produced the venous occlusion necessary for measurement of blood flow. The lowest venous occlusion pressure required to obtain the maximum rate of increase in calf and foot volume was determined at the beginning of each experiment and averaged 30 mm Hg for the calves and 42 mm Hg for the feet.
Water-level fluctuations in the plethysmographs were detected by Sanborn displacement transducers which sense the vertical motion of a 4-inch-diameter Lucite float. The transducers were used in conjunction with Sanborn strain gauge amplifiers and a direct-writing recorder. The recording system was calibrated at the beginning and end of each experiment by introducing known quantities of water into the plethysmograph. The volumes of the calf and foot within the plethysmographs were determined after the experiment by measurement of the water displaced. Radial pulse rates and sphygmomanometric blood pressure determinations were obtained with each set of flow measurements. Mean blood pressure was calculated by adding one third of the pulse pressure to the diastolic pressure.
Twelve normal subjects (eight males and four females) were studied; their ages averaged 24 years and ranged from 20 to 34 years. On each test day, the subjects were acclimated to a room temperature of 83 F for one hour. Three calf and foot blood flows were then recorded every ten minutes. After three sets of flows were obtained, the room temperature was lowered to 68 F. Three sets of blood flows were again recorded at the end of one hour in the cool environment. Foot blood flows were obtained in the warm and cool rooms in three patients who had had lumbar sympathectomies at least six months prior to the study. The sympathectomies had been performed for vasospastic disease or hyperhidrosis.
After a control study (predrug) was performed on each subject, either guanethidine (40 mg daily for two weeks; eight subjects) or reserpine (1 mg daily for three weeks; eight subjects) was given. If postural hypotension was not present after one week of guanethidine administration, the dose was raised to 50 or 60 mg daily; this was necessary in four of eight subjects. Blood flow studies were repeated on the last day of drug ingestion.
Four to eight months (average 6.4 months) following the drug study, a second (postdrug) control study was performed. Resting blood pressure and pulse rates were obtained before and during drug administration in all subjects.
Blood pressures in the lying and standing positions, before and after ("overshoot") the Valsalva maneuver, and before and immediately following exercise (walking up and down two steps 20 times), were measured before and during drug ingestion in all subjects on guanethidine.
Blood flow was expressed in ml per 100 ml of tissue per minute. Vascular resistance in arbitrary units was obtained by dividing the mean blood pressure by blood flow. Statistical analyses were performed as described by Snedecor.6 All statistical results were obtained by the Student t-test method with each individual serving as his own control. A probability level of less than 0.05 was considered significant.
Results

Guanethidine
Body cooling produced a significant decrease in foot and calf blood flows and increase in vascular resistance (P < 0.05) in both the control and the drug studies, except that calf vascular resistance (P <0.2) was not significantly changed by cooling during guanethidine administration. Table 1 shows the foot Table 1 Blood Flows in the Guanethidine and calf blood flows for the control and guanethidine studies. It is important to note that three subjects had low calf blood flows in the warm environment during guanethidine administration (2.2 to 2.8 ml/100 ml of tissue/ minute), and this may be the reason that a significant increase in calf vascular resistance was not obtained with body cooling during guanethidine administration. guanethidine administration when compared with the predrug, but not the postdrug, study.
Reserpine
Body cooling produced a significant decrease in foot and calf blood flows and increase in vascular resistance (P <0.01) in both the control and drug studies with reserpine. Table 3 shows the foot and calf blood flows for the control and reserpine studies. Table 4 depicts the average foot and calf blood flows and vascular resistances in the warm and cool rooms. No significant differences were obtained when the calf flow and resistance values in each environment were compared statistically, control to control, and each control to reserpine, except for a smaller calf blood flow in the 83-F room during reserpine administration compared with the predrug, but not the postdrug, study. A significantly lower foot resistance (P < 0.01) in the 68-F room occurred with reserpine, in comparison with the predrug, but not the postdrug, control study. Pulse Rate, Blood Pressure, and Side Effects Average pulse rates and mean blood pressures of the drug studies were compared statistically with values obtained in each control study. Also, the data from the predrug control study were compared with those from the postdrug control study.
Guanethidine
Resting pulse rate averaged 72 ± 9.3 (standard deviation) for the predrug control studies and 64±7.3 beats/minute with guanethidine (P < 0.02); the pulse rate averaged 74 ± 10.4 beats/minute for the postdrug control studies (P < 0.02 compared with guanethidine studies). Resting mean blood pressure averaged 86 ± 8.6 for the predrug control studies and 83 ± 8.6 mm Hg with guanethidine (P > *Flow in ml/100 ml of tissue/minute. Mean value and standard deviation. tAbbreviations: R =vascular resistance (mean blood pressure/flow); Cl = first control study; G = guanethidine study; and C2 = second control study. 4Student t-tests were performed with each individual serving as his own control. 0.5); the mean blood pressure of the postdrug control studies averaged 83 + 5.0 mm Hg (P < 0.3 compared with guanethidine studies). There was no significant difference between the two control tests in pulse rate (P> 0.5) or blood pressure (P < 0.1). In all eight subjects, the average control rise in systolic blood pressure on standing was 5 + 7.5 mm Hg; during guanethidine administration, no subject showed a rise in blood pressure and the average fall was 17 8.5 mm Hg. All subjects showed a control "overshoot" of systolic blood pressure after the Valsalva maneuver which averaged 21 + 6.6 mm Hg, while during guanethidine administration, only three subjects showed a systolic "overshoot" (an attenuated one) and there was an average decrease in systolic blood pressure of 2+7.6 mm Hg (P<0.001). Before drug ingestion, the subjects had an average rise in systolic blood pressure of 19 16.5 mm Hg following exercise. During guanethidine administration, no subject had a rise in systolic blood pressure following exercise; there was an average decrease of 32 + 37.4 mm Hg.
Seven of the eight subjects experienced dizziness on standing or during exercise, six had diarrhea, two had nasal congestion, and two were generally tired.
Reserpine
Resting pulse rate averaged 76 + 7.7 for the predrug control studies and 65±9.0 beats/minute with reserpine (P <0.001). In the postdrug control studies, the pulse rate averaged 78 7.7 beats/minute, which was also significantly different from the drug studies (P <0.01). Resting mean blood pressure averaged 87 + 4.4 for the predrug control studies and 80 6.7 mm Hg during drug administration (P < 0.02); the average blood pressure of the postdrug control studies averaged 88 + 5.0 mm Hg (P < 0.05 compared with reserpine studies ).
There was no significant difference between the two control tests in pulse rate (P> 0.5) and mean blood pressure (P > 0.5). Only two Circulation, Volume of the eight subjects on reserpine were studied for other effects. During drug administration, both subjects showed a 4 mm Hg drop in systolic blood pressure upon rising from the lying to the standing position, compared with a 22 and 26 mm Hg rise before the drug. The rise in systolic blood pressure following the Valsalva maneuver was abolished in both subjects, while the rise in systolic blood pressure after exercise was attenuated in only one of the two subjects. All subjects on reserpine experienced nasal congestion, six were generally tired and slept Circulation, Volume XXXV, February 1967 more than usual, two had diarrhea, and one was dizzy during exercise.
Sympathectomized Patients
Foot blood flow was studied in the warm and cool rooms in three patients with lumbar sympathectomies. Each patient had a small decrease in foot blood flow with body cooling. Warm-room foot flow averaged 7.3 (range, 5.0 to 10.1) and vascular resistance 15.8 (range, 9.4 to 25.2), while cool-room flow averaged 6.1 (range, 4.5 to 7.9) ml/100 ml of tissue/minute and vascular resistance 18.8 (range, 12.5 to 28.2) units.
Discussion
Wilkins and Eichna5 demonstrated that the vasoconstriction which occurs in the forearm and calf during body cooling is mediated by the sympathetic nervous system. In our study, the three patients with lumbar sympathectomies showed only small decreases in foot blood flow and increases in vascular resistance compared with the large changes seen in our normal subjects. Therefore, vasoconstriction in the foot is also almost entirely mediated through the sympathetic nervous system during body cooling. The small changes which occurred in the sympathectomized limbs may have been due to incomplete sympathetic denervation, a circulating-hormonal substance, or both.
In this study, guanethidine and reserpine administered for two and three weeks, respectively, did not produce a statistically significant attenuation of the vasoconstrictor activity stimulated by body cooling. Body cooling produced a significant decrease in blood flow and increase in vascular resistance in the foot and calf (which were not locally exposed to the cooling stimulus). Only during guanethidine administration was the increase in calf vascular resistance in response to cooling not statistically significant. However, three of the four subjects on guanethidine who showed no or small decreases in calf blood flow during body cooling had low calf blood flows in the warm environment and may have been vasoconstricted before body cooling. The apparent attenuation of vasoconstriction sometimes tAbbreviations: R vascular resistance (mean blood pressure/flow); Clfirst control study; Res = reserpine study; and C2 second control study. tStudent t-tests were performed with each individual serving as his own control.
obtained when the drug studies were compared with one of the control studies (for example, reserpine and foot vascular resistance) was not found when the other control study was used for comparison. Persistence of the drug actions is not probable, as postdrug studies were performed at least four months after discontinuation of the drug. Other investigators" 7have reported similar results when a second control study was used. It may be that the differences observed between the predrug or postdrug control studies and the drug studies were secondary to normal variations and not to an action of the drug. Although the environment of the present studies was strictly controlled, the subject may have reacted differently during the second and third tests when he had become more accustomed to the procedure.
It is possible that the dosages of guanethidine or reserpine were too small or that the drugs were not given for a sufficient length of time to decrease sympathetic nervous system activity. However, all subjects had un-equivocal side effects from the drugs. The significant decrease in pulse rate with reserpine and guanethidine and the attenuation of the Valsalva maneuver "overshoot," the postural hypotension, and the often dramatic hypotensive effect of muscular exercise with guanethidine showed that the drugs were used in doses adequate to inhibit considerable sympathetic nervous system activity.
Mason and Braunwald' were able to attenuate or block the forearm arterial and venous reflex sympathetic constrictor response to an ice water stimulus in subjects on guanethidine or reserpine. They gave the drugs for a longer period of time but in smaller doses than in our study; our subjects had more side effects. Pulse rate changes and the Valsalva maneuver "overshoot" tests during drug treatment were similar in the two studies. Sha- piro From the results of the present study, it can be concluded that large clinical doses of guanethidine or reserpine for two and three weeks, respectively, do not produce a statistically significant attenuation or blockade of the vasoconstrictor response to body cooling. Our stimulus for inducing sympathetic vasoconstrictor activity is different from the stimuli used in other studies in that it is applied to a wide body area and is prolonged for one hour. The sympathetic nervous system reflexes that are blocked or attenuated occur in response to a less generalized, shorter stimulus (that is, Valsalva maneuver, exposure of a hand to ice water, and so forth).
The persistence of a vasoconstrictor response in the foot and calf during body cooling could be secondary to any of three mechanisms. Increased blood vessel sensitivity to circulating norepinephrine may be present during guanethidine and reserpine administration8 9; norepinephrine may be released from the adrenal medulla by the prolonged stimulus. However, this is an unlikely explanation, since sympathectomized patients do not show a pronounced vasoconstrictor response to body cooling. Another possibility is that acute reflex sympathetic responses are dependent on neurotransmitter stores that are depleted by guanethidine or reserpine, while responses to more prolonged stimuli are mediated by neurotransmitter substance continuously synthesized at the nerve endings. A final explanation could be that guanethidine and reserpine do not entirely deplete the tissue stores of catecholamines in man, but that the remaining stores can be released only by prolonged stimuli. It is not clear at present which of the latter two mechanisms accounts for the persistence of a vasoconstrictor response in this study.
Other studies provide further evidence that neurotransmitter substance is present in subjects on guanethidine and reserpine. Cohn and associates2 were able to elicit a pres-Circulation, Volume XXXV, February 1967 sor response to tyramine in their subjects on guanethidine who had inhibition of some sympathetic nervous responses. Despite studies to the contrary,7' 10, 11 other investiga-tors12- 5 have also found pressor responses to tyramine or ephedrine during guanethidine or reserpine administration.
Agents which block the sympathetic nervous system or deplete catecholamines from sympathetic nerve endings have been recommended in the treatment of peripheral vasospastic disease, especially Raynaud's disease. The evidence for attenuation or blockade of sympathetic nervous system responses to the acute stimuli of cold water exposure and mental stress supports the use of these drugs for this purpose. However, the results of the present study would indicate that these drugs should not be relied upon to protect these patients against a generalized exposure such as cold weather. The absence of a statistically significant difference between control and drug cool-room blood flow and vascular resistance values is especially pertinent in this regard.
